435 related articles for article (PubMed ID: 27965285)
1. Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials.
Bivard A; Huang X; McElduff P; Levi CR; Campbell BC; Cheripelli BK; Kalladka D; Moreton FC; Ford I; Bladin CF; Davis SM; Donnan GA; Muir KW; Parsons MW
Circulation; 2017 Jan; 135(5):440-448. PubMed ID: 27965285
[TBL] [Abstract][Full Text] [Related]
2. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.
Parsons MW; Miteff F; Bateman GA; Spratt N; Loiselle A; Attia J; Levi CR
Neurology; 2009 Mar; 72(10):915-21. PubMed ID: 19273826
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
Parsons M; Spratt N; Bivard A; Campbell B; Chung K; Miteff F; O'Brien B; Bladin C; McElduff P; Allen C; Bateman G; Donnan G; Davis S; Levi C
N Engl J Med; 2012 Mar; 366(12):1099-107. PubMed ID: 22435369
[TBL] [Abstract][Full Text] [Related]
4. Tenecteplase in ischemic stroke offers improved recanalization: Analysis of 2 trials.
Bivard A; Huang X; Levi CR; Spratt N; Campbell BCV; Cheripelli BK; Kalladka D; Moreton FC; Ford I; Bladin CF; Davis SM; Donnan GA; Muir KW; Parsons MW
Neurology; 2017 Jul; 89(1):62-67. PubMed ID: 28576782
[TBL] [Abstract][Full Text] [Related]
5. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol.
Bivard A; Garcia-Esperon C; Churilov L; Spratt N; Russell M; Campbell BC; Choi P; Kleinig T; Ma H; Markus H; Molina C; Hsu C; Tsai CH; Meretoja A; Strbian D; Butcher K; Wu T; Davis S; Donnan G; Levi C; Parsons M
Int J Stroke; 2023 Jul; 18(6):751-756. PubMed ID: 36655938
[TBL] [Abstract][Full Text] [Related]
6. Comparing mismatch strategies for patients being considered for ischemic stroke tenecteplase trials.
Bivard A; Huang X; Levi CR; Campbell BC; Cheripelli BK; Chen C; Kalladka D; Moreton FC; Ford I; Davis SM; Donnan GA; Muir KW; Parsons MW
Int J Stroke; 2020 Jul; 15(5):507-515. PubMed ID: 31684841
[TBL] [Abstract][Full Text] [Related]
7. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
[TBL] [Abstract][Full Text] [Related]
8. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial.
Singh N; Almekhlafi MA; Bala F; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Buck B; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Ghrooda E; Poppe AY; Williams H; Field TS; Manosalva A; Siddiqui MM; Zafar A; Imoukhoude O; Hunter G; Shamy M; Demchuk AM; Claggett BL; Hill MD; Sajobi TT; Swartz RH; Menon BK
Stroke; 2023 Nov; 54(11):2766-2775. PubMed ID: 37800372
[TBL] [Abstract][Full Text] [Related]
9. Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale.
Rønning OM; Logallo N; Thommessen B; Tobro H; Novotny V; Kvistad CE; Aamodt AH; Næss H; Waje-Andreassen U; Thomassen L
Stroke; 2019 Feb; 50(2):498-500. PubMed ID: 30602354
[TBL] [Abstract][Full Text] [Related]
10. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Dewey HM; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi CR; Rodrigues E; Zhao H; Salvaris P; Garcia-Esperon C; Bailey P; Rice H; de Villiers L; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Wong AA; Muller C; Coulthard A; Mitchell K; Clouston J; Mahady K; Field D; Ma H; Phan TG; Chong W; Chandra RV; Slater LA; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
N Engl J Med; 2018 Apr; 378(17):1573-1582. PubMed ID: 29694815
[TBL] [Abstract][Full Text] [Related]
11. Reduced Severity of Tissue Injury Within the Infarct May Partially Mediate the Benefit of Reperfusion in Ischemic Stroke.
Ng FC; Churilov L; Yassi N; Kleinig TJ; Thijs V; Wu TY; Shah DG; Dewey HM; Sharma G; Desmond PM; Yan B; Parsons MW; Donnan GA; Davis SM; Mitchell PJ; Leigh R; Campbell BCV;
Stroke; 2022 Jun; 53(6):1915-1923. PubMed ID: 35135319
[TBL] [Abstract][Full Text] [Related]
12. Tenecteplase, 0.4 mg/kg, in Moderate and Severe Acute Ischemic Stroke: A Pooled Analysis of NOR-TEST and NOR-TEST 2A.
Novotny V; Kvistad CE; Naess H; Logallo N; Fromm A; Khanevski AN; Thomassen L
J Am Heart Assoc; 2023 Oct; 12(20):e030320. PubMed ID: 37830342
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and safety profile of Tenecteplase in wake-up stroke.
Ahmed HK; Logallo N; Thomassen L; Novotny V; Mathisen SM; Kurz MW
Acta Neurol Scand; 2020 Nov; 142(5):475-479. PubMed ID: 32511749
[TBL] [Abstract][Full Text] [Related]
14. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
[TBL] [Abstract][Full Text] [Related]
15. Association of Reperfusion After Thrombolysis With Clinical Outcome Across the 4.5- to 9-Hours and Wake-up Stroke Time Window: A Meta-Analysis of the EXTEND and EPITHET Randomized Clinical Trials.
Campbell BCV; Ma H; Parsons MW; Churilov L; Yassi N; Kleinig TJ; Hsu CY; Dewey HM; Butcher KS; Yan B; Desmond PM; Wijeratne T; Curtze S; Barber PA; De Silva DA; Thijs V; Levi CR; Bladin CF; Sharma G; Bivard A; Donnan GA; Davis SM
JAMA Neurol; 2021 Feb; 78(2):236-240. PubMed ID: 33137171
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
Bivard A; Zhao H; Churilov L; Campbell BCV; Coote S; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski AH; Dos Santos A; Ng JL; Yogendrakumar V; Ng F; Langenberg F; Easton D; Warwick A; Mackey E; MacDonald A; Sharma G; Stephenson M; Smith K; Anderson D; Choi P; Thijs V; Ma H; Cloud GC; Wijeratne T; Olenko L; Italiano D; Davis SM; Donnan GA; Parsons MW;
Lancet Neurol; 2022 Jun; 21(6):520-527. PubMed ID: 35525251
[TBL] [Abstract][Full Text] [Related]
17. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
[TBL] [Abstract][Full Text] [Related]
18. The Impact of CT Perfusion Threshold on Predicted Viable and Nonviable Tissue Volumes in Acute Ischemic Stroke.
Huang X; Kalladka D; Cheripelli BK; Moreton FC; Muir KW
J Neuroimaging; 2017 Nov; 27(6):602-606. PubMed ID: 28414895
[TBL] [Abstract][Full Text] [Related]
19. Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Haykal T; Ahmed S; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
J Thromb Thrombolysis; 2018 Nov; 46(4):440-450. PubMed ID: 30117036
[TBL] [Abstract][Full Text] [Related]
20. Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core.
Gerschenfeld G; Turc G; Obadia M; Chausson N; Consoli A; Olindo S; Caroff J; Marnat G; Blanc R; Ben Hassen W; Seners P; Guillon B; Wiener E; Bourcier R; Yger M; Cho TH; Checkouri T; Gory B; Smadja D; Sibon I; Richard S; Piotin M; Eker OF; Pico F; Lapergue B; Alamowitch S;
Neurology; 2024 Jul; 103(1):e209398. PubMed ID: 38862134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
